Propanc Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Camberwell, Victoria, Australia
SEC filing record 1 source field available
Fiscal year end
30 June
Propanc Biopharma, Inc. has filed 432 SEC EDGAR filings since 23 Jun 2011

SEC filing history

Showing 376-400 of 432 matching filings.

Per page
25
Current page
16
8-K File 000-54878

FORM 8-K

Filing date
22 Sep 2014
Reporting date
29 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54878

QUARTERLY REPORT

Filing date
20 May 2014
Reporting date
31 Mar 2014
Next action
Verify source filing
NT 10-Q File 000-54878

LATE FILING NOTIFICATION

Filing date
13 May 2014
Reporting date
31 Mar 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54878

QUARTERLY REPORT

Filing date
14 Feb 2014
Reporting date
31 Dec 2013
Next action
Verify source filing
10-Q File 000-54878

QUARTERLY REPORT

Filing date
14 Nov 2013
Reporting date
13 Nov 2013
Next action
Verify source filing
10-K File 000-54878

ANNUAL REPORT

Filing date
15 Oct 2013
Reporting date
30 Jun 2013
Next action
Verify source filing
NT 10-K File 000-54878

LATE FILING NOTICE

Filing date
26 Sep 2013
Reporting date
30 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87562

SC 13G filing

Filing date
02 Aug 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54878

QUARTERLY REPORT

Filing date
20 May 2013
Reporting date
31 Mar 2013
Next action
Verify source filing
NT 10-Q File 000-54878

NOTICE OF LATE FILING

Filing date
15 May 2013
Reporting date
31 Mar 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-196149

D filing

Filing date
08 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-54878

LATE FILING NOTICE

Filing date
14 Feb 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12G File 000-54878

REGISTRATION

Filing date
11 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-175092

EFFECT filing

Filing date
10 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
07 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-175092

NO. 3

Filing date
07 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-175092

NO. 2

Filing date
17 Dec 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 333-175092

FORM 10-Q

Filing date
19 Nov 2012
Reporting date
30 Sep 2012
Next action
Verify source filing
NT 10-Q File 333-175092

NOTIFICATION OF LATE FILING

Filing date
13 Nov 2012
Reporting date
30 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 333-175092

ANNUAL REPORT

Filing date
15 Oct 2012
Reporting date
11 Oct 2012
Next action
Verify source filing
NT 10-K File 333-175092

LATE FILING NOTICE

Filing date
27 Sep 2012
Reporting date
30 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Aug 2012
Reporting date
23 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

PRIMARY DOCUMENT

Filing date
22 Aug 2012
Reporting date
16 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .